20 studies were found.

1.		Completed	BMS-247550 Plus Cisplatin in Treating Patients With Metastatic or Recurrent Head and Neck Cancer Conditions: Hypopharyngeal Cancer; Laryngeal Cancer; lip and oral cavity cancer; Oropharyngeal Cancer; paranasal sinus and nasal cavity cancer; ...
2.		No longer recruiting	Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia Conditions: accelerated phase chronic myelogenous leukemia; refractory chronic myelogenous leukemia; chronic phase chronic myelogenous leukemia
3.		Recruiting	Bortezomib in Treating Patients With Advanced Non-small Cell Lung Cancer Conditions: recurrent non-small cell lung cancer; stage IIIB non-small cell lung cancer; stage IV non-small cell lung cancer
4.		Recruiting	Combination Chemotherapy Followed By Tipifarnib Plus Radiation Therapy in Treating Patients With Stage III Non-Small Cell Lung Cancer Conditions: stage IIIA non-small cell lung cancer; stage IIIB non-small cell lung cancer
5.		Recruiting	EF5 and Motexafin Lutetium in Detecting Tumor Cells in Patients With Abdominal Cancer Conditions: Endocrine Cancer; female reproductive cancer; Gastrointestinal Cancer; musculoskeletal cancer; unclassified and other cancer
6.		Recruiting	EF5 in Detecting Oxygen Level and Blood Vessels in Tumor Cells of Patients Undergoing Photodynamic Therapy for Intraperitoneal or Pleural Cancer Conditions: malignant ascites; peritoneal cavity cancer; advanced malignant mesothelioma; localized malignant mesothelioma; recurrent malignant mesothelioma
7.		Recruiting	EF5 in Treating Patients With Solid Tumors Condition: unspecified adult solid tumor, protocol specific
8.		No longer recruiting	Gefitinib and Combination Chemotherapy in Treating Patients With Advanced or Recurrent Colorectal Cancer Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; adenocarcinoma of the colon; ...
9.		Completed	Gene Therapy in Treating Patients With Primary Brain Tumors Conditions: Brain Tumor; Glioblastoma; Astrocytoma
10.		Recruiting	Imatinib Mesylate and Bevacizumab in Treating Patients With Advanced Melanoma or Other Advanced Cancers Conditions: stage III melanoma; Stage IV Melanoma; Recurrent Melanoma; unspecified adult solid tumor, protocol specific
11.		Recruiting	Interleukin-12 and Interleukin-2 in Treating Patients With Mycosis Fungoides Conditions: Cutaneous T-Cell Lymphoma; mycosis fungoides and Sezary syndrome
12.		Recruiting	Intrapleural BG00001 in Treating Patients With Malignant Pleural Mesothelioma or Malignant Pleural Effusions Condition: Cancer
13.		Completed	Irinotecan Plus ICI D1694 in Treating Patients With Advanced Solid Tumors Condition: unspecified adult solid tumor, protocol specific
14.		Completed	MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer Condition: Breast Cancer
15.		No longer recruiting	MRI to Detect Breast Tumors in Women Condition: Breast Cancer
16.		Recruiting	Photodynamic Therapy With Lutetium Texaphyrin in Treating Patients With Locally Recurrent Prostate Cancer Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; recurrent prostate cancer
17.		No longer recruiting	Surgery, Radiation Therapy, and Combination Chemotherapy in Treating Patients With Recurrent Head and Neck Cancer Conditions: Oral Cancer; Throat Cancer; Nose Cancer
18.		Recruiting	Tipifarnib and Radiation Therapy in Treating Patients With Unresectable Locally Advanced Pancreatic Cancer Conditions: stage II pancreatic cancer; stage III pancreatic cancer; recurrent pancreatic cancer
19.		Recruiting	Vaccine Plus Montanide ISA-51 and Sargramostim in Treating Patients With Stage IV Breast Cancer Conditions: recurrent breast cancer; stage IV breast cancer
20.		No longer recruiting	Vaccine Therapy in Treating Patients With Stage IV Melanoma Conditions: Stage IV Melanoma; Recurrent Melanoma